Metrics

Reasons why access cannot be provided (enquiries for Novartis studies)

Reason	Number of studies
Out of scope - ongoing related extension studies	1
Out of scope - Phase 1 study	106
Out of scope - Phase 4 study	7
Out of scope - study still ongoing	75
Out of scope - unapproved indication	15
Out of scope - risk of reidentification due to small number of patients	4
Out of scope - Could not identify study with information provided	11
Out of scope - Asset divested to another company	32
Data too old; not compatible with current anonymization applications	10
Novartis is not the sponsor of the requested study	24
Out of scope - cancelled studies	4
Out of scope - observational/expanded access studies	5
Novartis declined to share	2

Proposal number	Study Sponsor(s)/funder(s)	Reason(s)
615	GSK	The Research Proposal is not seeking access to anonymised patient level data
618	GSK	The Research Proposal is not seeking access to anonymised patient level data
633	GSK	The Research Proposal is not seeking access to anonymised patient level data
690	GSK	The Research Proposal is not seeking access to anonymised patient level data
931	BI/GSK	The Research Proposal did not meet the Sponsor policies for informed consent
938	BI/GSK/Roche	The Research Proposal is not seeking access to anonymised patient level data
941	Roche	The Research Proposal is not seeking access to anonymised patient level data
1047	GSK	The Research Proposal is not seeking access to anonymised patient level data
1087	GSK	The Research Proposal is not seeking access to anonymised patient level data
1107	GSK	The Research Proposal is not seeking access to anonymised patient level data
1552	Novartis	The proposed research required data that was not collected in the studies requested
1235	BI	The Research Proposal competes with the Sponsor's publication plan
1245	BI	The Research Proposal competes with the Sponsor's publication plan
1589	Novartis	The Research Proposal is not seeking access to anonymised patient level data